Hereditary angioedema Types 1 or 2 - garadacimab or lanadelumab - initial or change authority application form (PB325)

Use this form to apply for initial or changing PBS-subsidised treatment.

This form can be used to apply for:

  • garadacimab for patients with hereditary angioedema Types 1 or 2
  • lanadelumab for patients aged 12 years or older with hereditary angioedema Types 1 or 2.

Please note: You don’t need to complete this form if you use the Online PBS Authorities system.

Download and complete the hereditary angioedema Types 1 or 2 - garadacimab or lanadelumab - initial or change authority application form.

Page last updated: 2 April 2026.
QC 55886